Novartis is buying dry-eye medicine brand ‘Xiidra’ from Takeda Pharmaceutical for up to $5.3 billion as the Swiss pharma-maker refreshes its ophthalmic medicines portfolio with a potential blockbuster. The deal calls for $3.4 billion up front and milestone payments up to $1.9 billion, Novartis said.
Neopharma, a leading global pharmaceutical company based in the UAE and GlaxoSmithKline (GSK) the global science-led healthcare company, have announced the launch of the first ever locally produced batch of medicines,
We’re crawling on your skin. Teeming under your toenails. And lurking on your doorknobs and countertops. We’re drug-resistant microbes, immune to all but your strongest antibiotics.
Dubai Economy issued fines to nine pharmacies and two pharmaceuticals suppliers for inflating the prices of face masks and trying to take undue advantage of the high demand for hygiene essentials following the nationwide alert against the Covid-19 pandemic.